Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Studies over the last few years have clearly established that at least 25% of men with type 2 diabetes have subnormal free testosterone concentrations in association with inappropriately low LH and FSH concentrations. Another 4% have subnormal testosterone concentrations with elevated LH and FSH concentrations. The Endocrine Society, therefore, now recommends the measurement of testosterone in patients with type 2 diabetes on a routine basis. The subnormal testosterone concentrations are not related to glycosylated hemoglobin or duration of diabetes, but are associated with obesity, very high C-reactive protein concentrations, and mild anemia. In addition, subnormal testosterone concentrations in these men are associated with a two to three times elevated risk of cardiovascular events and death in two early studies. Short-term studies of testosterone therapy in hypogonadal men with type 2 diabetes have demonstrated an increase in insulin sensitivity and a decrease in waist circumference. However, the data on the effect of testosterone replacement on glycemic control and cardiovascular risk factors such as cholesterol and C-reactive protein concentrations are inconsistent. As far as sexual function is concerned, testosterone treatment increases libido but does not improve erectile dysfunction and thus, phosphodiesterase inhibitors may be required. Trials of a longer duration are clearly required to definitively establish the benefits and risks of testosterone replacement in patients with type 2 diabetes and low testosterone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Obese subjects often have reduced gonadotropin concentrations indicating that the primary effect is mediated at the hypothalamus-pituitary level rather than at the testicular level [38].”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increased amount of estrogen levels might, in turn, play a negative feedback on both the hypothalamus and the pituitary, leading to decreased LH secretion (22,55).”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [55]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus high BMI seems to repress serum T mainly via central inhibitory effects on gonadotropin secretion [38, 41].”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“Based on these and other studies (53,54), obesity-related male hypogonadism is now considered as a form of hypogonadotropic hypogonadism (see for a review, references (55,56)).”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“Accordingly, patients with T2DM and insulin resistance show a higher prevalence of hypogonadotropic hypogonadism (54,55,60)”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
Self-citationAdverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Khosla, S., Amin, S., & Orwoll, E. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0002 · Cited by 930
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1036 · Cited by 920
Low Serum Testosterone and Mortality in Older Men
Laughlin, G. A., Barrett-Connor, E., & Bergstrom, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1792 · Cited by 798
Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791
Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N. (2007) · Circulation · doi:10.1161/circulationaha.107.719005 · Cited by 743
Sex hormone-binding globulin and risk of type 2 diabetes in women and men
Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C. C., Rifai, N., Buring, J. E., Gaziano, J. M., & Liu, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804381 · Cited by 726
Cited by
Sex differences in the physiology of eating
Asarian, L., & Geary, N. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00446.2012 · Cited by 513
Corona, G., Rastrelli, G., Monami, M., Saad, F., Luconi, M., Lucchese, M., Facchiano, E., Sforza, A., Forti, G., Mannucci, E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0955 · Cited by 414
Diabetes and sexual dysfunction: current perspectives
Esposito, K., Maiorino, M. I., & Bellastella, G. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s36455 · Cited by 342
“which may suppress the secretion of gonadotropin-releasing hormone and LH.(62,71) Bellastella et al(72) suggested a possible”
Obesity, male infertility, and the sperm epigenome
Craig, J. R., Jenkins, T. G., Carrell, D. T., & Hotaling, J. M. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.02.115 · Cited by 318
Erectile dysfunction and diabetes: A melting pot of circumstances and treatments
Defeudis, G., Mazzilli, R., Tenuta, M., Rossini, G., Zamponi, V., Olana, S., Faggiano, A., Pozzilli, P., Isidori, A. M., & Gianfrilli, D. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3494 · Cited by 285
Dhindsa, S., Ghanim, H., Batra, M., Kuhadiya, N. D., Abuaysheh, S., Sandhu, S., Green, K., Makdissi, A., Hejna, J., Chaudhuri, A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1518 · Cited by 286
“The first report of frequent occurrence of subnormal free testosterone concentrations in males with type 2 diabetes demonstrated that while the duration of diabetes or the quality of its control had no relationship with plasma testosterone concentrations, the latter were inversely related to BMI (1,2).”
BackgroundSelf-citationMetabolic regulation of kisspeptin — the link between energy balance and reproduction
Navarro, V. M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0363-7 · Cited by 240
Obesity and reproduction: a committee opinion
Penzias, A., Azziz, R., Bendikson, K., Falcone, T., Hansen, K., Hill, M., Jindal, S., Kalra, S., Mersereau, J., Reindollar, R., et al. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.08.018 · Cited by 222
“The mechanisms by which obesity may result in diminished semen quality and male factor infertility include endocrine alterations, sexual dysfunction, and other medical issues including diabetes mellitus (118), sleep apnea (119), or scrotal hyperthermia due to body habitus (120–122).”
BackgroundMechanisms linking obesity with male infertility
Katib, A. (2015) · Central European Journal of Urology · doi:10.5173/ceju.2015.01.435 · Cited by 203
European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
Pasquali, R., Casanueva, F., Haluzik, M., van Hulsteijn, L., Ledoux, S., Monteiro, M. P., Salvador, J., Santini, F., Toplak, H., & Dekkers, O. M. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0893 · Cited by 188
Gianatti, E. J., Dupuis, P., Hoermann, R., Strauss, B. J., Wentworth, J. M., Zajac, J. D., & Grossmann, M. (2014) · Diabetes Care · doi:10.2337/dc13-2845 · Cited by 168
“As expected (16,23), values measured by LCMS/MS were higher than those obtained by immunoassay.”
BackgroundMethodHypogonadotropic Hypogonadism in Men With Diabesity
Dhindsa, S., Ghanim, H., Batra, M., & Dandona, P. (2018) · Diabetes Care · doi:10.2337/dc17-2510 · Cited by 158
“Isolated knockout of the insulin receptor in a GnRH neuron does not lead to a decrease in LH concentrations or in fertility in either male or female mice (31).”
BackgroundInfluentialSelf-citationSaboor Aftab, S. A., Kumar, S., & Barber, T. M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12092 · Cited by 157
Maiorino, M. I., Bellastella, G., Giugliano, D., & Esposito, K. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0872-6 · Cited by 155
“Hypogonadism is a frequent comorbidity of type 2 diabetes, occurring in about one-third of diabetic men, where it seems to correlate with obesity and very high C-reactive protein concentrations, rather than duration of the disease or glycemic control [63].”
BackgroundLifestyle modifications and erectile dysfunction: what can be expected?
Esposito, K., Maiorino, M., & Bellastella, G. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.137687 · Cited by 139
George, J. T., Veldhuis, J. D., Tena‐Sempere, M., Millar, R. P., & Anderson, R. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12103 · Cited by 105
Zhao, J., Zhai, L., Liu, Z., Wu, S., & Xu, L. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/190945 · Cited by 133
Metabolic and Endocrine Consequences of Bariatric Surgery
Cornejo-Pareja, I. M., Clemente‐Postigo, M., & Tinahones, F. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00626 · Cited by 147
Hypogonadotropic Hypogonadism in Morbidly Obese Males Is Reversed After Bariatric Surgery
Pellitero, S., Olaizola, I., Alastrue, A., Martínez-Cáceres, E. M., Granada, M. L., Balibrea, J. M., Moreno, P., Serra, A., Navarro-Díaz, M., Romero, R., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0734-9 · Cited by 127
“Hypogonadism is a peculiar feature of abdominal obesity that independently predicts the development of insulin resistance and diabetes mellitus [9, 32].”
BackgroundThe role of sex steroids in white adipose tissue adipocyte function
Newell-Fugate, A. E. (2017) · Reproduction · doi:10.1530/rep-16-0417 · Cited by 114
“By contrast, overweight men with visceral adipose tissue accumulation are at risk for hypogonadism, low androgen levels and type II diabetes (Dandona & Dhindsa 2011).”
Background20 YEARS OF LEPTIN: Role of leptin in human reproductive disorders
Chou, S. H., & Mantzoros, C. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0245 · Cited by 107
Cheung, K. K. T., Luk, A. O. Y., So, W. Y., Ma, R. C. W., Kong, A. P. S., Chow, F. C. C., & Chan, J. C. N. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12288 · Cited by 102
Eriksson, J., Haring, R., Grarup, N., Vandenput, L., Wallaschofski, H., Lorentzen, E., Hansen, T., Mellström, D., Pedersen, O., Nauck, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176277 · Cited by 101
“Thus high BMI seems to repress serum T mainly via central inhibitory effects on gonadotropin secretion [38, 41].”
BackgroundHannema, S. E., van Duyvenvoorde, H. A., Premsler, T., Yang, R., Mueller, T. D., Gaßner, B., Oberwinkler, H., Roelfsema, F., Santen, G. W. E., Prickett, T. C. R., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2358 · Cited by 103
“Non-insulin-dependent diabetes mellitus (NIDDM) was diagnosed at age 53 years and is well controlled with metformin.”
BackgroundInfluentialTestosterone and glucose metabolism in men: current concepts and controversies
Grossmann, M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0393 · Cited by 100
Lotti, F., Corona, G., Degli Innocenti, S., Filimberti, E., Scognamiglio, V., Vignozzi, L., Forti, G., & Maggi, M. (2013) · Andrology · doi:10.1111/j.2047-2927.2012.00031.x · Cited by 96
“…did not rise according to the androgen fall, indicates an hypogonadotropic nature of the hypogonadism, as previously described in studies performed on animal models of MetS (Filippi et al., 2009; Corona et al., 2011b) and in human cohorts (Corona et al., 2009b; Dandona & Dhindsa, 2011).”
ResultDiabetic Complications in Obese Type 2 Diabetic Rat Models
Katsuda, Y., Ohta, T., Miyajima, K., Kemmochi, Y., Sasase, T., Tong, B., Shinohara, M., & Yamada, T. (2014) · Experimental Animals · doi:10.1538/expanim.63.121 · Cited by 95
“Sexual dysfunction it was reported that subnormal free testosterone concentrations were related with inappropriately low luteinizing hormone (Lh) and follicle-stimulating hormone (Fsh) concentrations and a normal response to gonadotropin-releasing hormone (gnrh) of Lh and Fsh in type 2 diabetes [10, 13].”
BackgroundPrevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study
Al Hayek, A., Khader, Y., Jafal, S., Khawaja, N., Robert, A., & Ajlouni, K. (2013) · Journal of Family and Community Medicine · doi:10.4103/2230-8229.122006 · Cited by 94
“[32] Considering the importance of the situation, The Endocrine Society recommends measuring the testosterone of patients with type 2 diabetes on a routine basis.[29,33]”
Physiology of Gnrh and Gonadotropin Secretion
Marques, P., Skorupskaite, K., George, J. T., & Anderson, R. A. (2015) · Cited by 101
Endogenous Sex Hormones, Metabolic Syndrome, and Diabetes in Men and Women
Kim, C., & Halter, J. B. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0467-6 · Cited by 111
Obesity and Male Infertility: A Practical Approach
Meikle, A., Reis, L., Gibson, M., Peterson, C., Carrell, D., & Hammoud, A. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1328877 · Cited by 88
Sex hormones, obesity and type 2 diabetes: is there a link?
Gambineri, A., & Pelusi, C. (2018) · Endocrine Connections · doi:10.1530/ec-18-0450 · Cited by 92
Kasuga, M., Ueki, K., Tajima, N., Noda, M., Ohashi, K., Noto, H., Goto, A., Ogawa, W., Sakai, R., Tsugane, S., et al. (2013) · Cancer Science · doi:10.1111/cas.12203 · Cited by 89
Testosterone concentrations in young pubertal and post-pubertal obese males
Mogri, M., Dhindsa, S., Quattrin, T., Ghanim, H., & Dandona, P. (2013) · Clinical Endocrinology · doi:10.1111/cen.12018 · Cited by 79
Self-citationNeuroanatomical Framework of the Metabolic Control of Reproduction
Hill, J. W., & Elias, C. F. (2018) · Physiological Reviews · doi:10.1152/physrev.00033.2017 · Cited by 89
“Individuals with T2D show relative decreases in LH pulsatility and disrupted sex steroid feedback, resulting in low gonadotropin levels (112).”
BackgroundHow much does obesity affect the male reproductive function?
Bellastella, G., Menafra, D., Puliani, G., Colao, A., & Savastano, S. (2019) · International Journal of Obesity Supplements · doi:10.1038/s41367-019-0008-2 · Cited by 90
Follicle-stimulating hormone associates with prediabetes and diabetes in postmenopausal women
Wang, N., Kuang, L., Han, B., Li, Q., Chen, Y., Zhu, C., Chen, Y., Xia, F., Cang, Z., Zhu, C., et al. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0769-1 · Cited by 81
“Inflammatory markers, such as C-reactive protein, TNF-a and IL-1b, not only were positively associated with estrone level [21], but also could suppress gonadotropin-releasing hormone release in animal studies [22], which is also common in diabetic men [23].”
BackgroundGiannetta, E., Gianfrilli, D., Barbagallo, F., Isidori, A. M., & Lenzi, A. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.005 · Cited by 79
Endocrinopathies and Male Infertility
Sengupta, P., Dutta, S., Karkada, I. R., & Chinni, S. V. (2021) · Life · doi:10.3390/life12010010 · Cited by 136
“According to the ‘The Endocrine Society Clinical Practice Guidelines (2010)’, men suffering from type 2 diabetes should undergo tests for low levels of testosterone [98].”
TRANSITION IN ENDOCRINOLOGY: Hypogonadism in adolescence
Dwyer, A. A., Phan-Hug, F., Hauschild, M., Elowe-Gruau, E., & Pitteloud, N. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0947 · Cited by 73
Goodman, N. F., Guay, A. T., Dandona, P., Dhindsa, S., Faiman, C., & Cunningham, G. R. (2015) · Endocrine Practice · doi:10.4158/ep14434.ps · Cited by 75
Self-citationWeight loss is a major contributor to improved sexual function after bariatric surgery
Mora, M., Aranda, G. B., de Hollanda, A., Flores, L., Puig-Domingo, M., & Vidal, J. (2013) · Surgical Endoscopy · doi:10.1007/s00464-013-2890-y · Cited by 70
Ross, A., & Bhasin, S. (2016) · Urologic Clinics of North America · doi:10.1016/j.ucl.2016.01.002 · Cited by 78
Insulin and Leptin Signaling Interact in the Mouse Kiss1 Neuron during the Peripubertal Period
Qiu, X., Dao, H., Wang, M., Heston, A., Garcia, K. M., Sangal, A., Dowling, A. R., Faulkner, L. D., Molitor, S. C., Elias, C. F., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121974 · Cited by 64
“Similarly, more than 25% of men with type 2 diabetes have hypothalamic hypogonadism [8].”
BackgroundMetabolic syndrome and sexual dysfunction
Schulster, M. L., Liang, S. E., & Najari, B. B. (2017) · Current Opinion in Urology · doi:10.1097/mou.0000000000000426 · Cited by 71
Testosterone increases GLUT4‐dependent glucose uptake in cardiomyocytes
Wilson, C., Contreras‐Ferrat, A. E., Venegas, N., Osorio‐Fuentealba, C., Pávez, M., Montoya, K., Durán, J., Maass, R., Lavandero, S., & Estrada, M. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24413 · Cited by 60
“Testosterone administration restores blood glucose levels to a normal range and reduces central obesity and insulin resistance, among other effects (Dhindsa et al., 2010; Dandona and Dhindsa, 2011; Jeong et al., 2011; Rubinow et al., 2011).”
BackgroundObesity, Male Reproductive Function and Bariatric Surgery
Vincenzo, A. D., Busetto, L., Vettor, R., & Rossato, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00769 · Cited by 66
Obesity and male infertility: multifaceted reproductive disruption
Chaudhuri, G. R., Das, A., Kesh, S. B., Bhattacharya, K., Dutta, S., Sengupta, P., & Syamal, A. K. (2022) · Middle East Fertility Society Journal · doi:10.1186/s43043-022-00099-2 · Cited by 74
“Secondary hypogonadism is often detected in individuals with moderate to severely obese male with a reported prevalence of about 45% [34] and also with higher prevalence rate than type-2 diabetes mellitus (T2DM) in obese males [35, 36].”
BackgroundObesity and male fertility disorders
Cannarella, R., Crafa, A., Curto, R., Condorelli, R. A., Vignera, S. L., & Calogero, A. E. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101273 · Cited by 75
Vesper, H. W., Wang, Y., Vidal, M., Botelho, J. C., & Caudill, S. P. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.245969 · Cited by 60
“Consistent with observations in other study groups (30), totalT values declined with increasing age in women.”
ResultMechanisms of Central Hypogonadism
Barber, T., Kyrou, I., Kaltsas, G., Grossman, A., Randeva, H., & Weickert, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158217 · Cited by 50
“In male obesity, especially in the context of type 2 diabetes (T2D), numerous other factors contribute towards the development of CH that include enhanced conversion of testosterone to oestradiol within adipose tissue from enhanced aromatase activity [86], and consequent central suppressive effects of oestradiol on th…”
BackgroundGüney, C., Bal, N. B., & Akar, F. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18896 · Cited by 60
“Also, the increased body mass index in males is associated with a reduced plasma level of testosterone with a concomitant increase in plasma level of estrogen [192].”
BackgroundType 2 Diabetes in the Elderly: Challenges in a Unique Patient Population
Bradley, D. P., & Hsueh, W. A. (2016) · Journal of Geriatric Medicine and Gerontology · doi:10.23937/2469-5858/1510014 · Cited by 68
The kisspeptin receptor: A key G-protein-coupled receptor in the control of the reproductive axis
Franssen, D., & Tena‐Sempere, M. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.01.005 · Cited by 71
Ablating astrocyte insulin receptors leads to delayed puberty and hypogonadism in mice
Manaserh, I. H., Chikkamenahalli, L. L., Ravi, S., Dube, P. R., Park, J. J., & Hill, J. W. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000189 · Cited by 56
Dhindsa, S., Ghanim, H., Batra, M., Kuhadiya, N. D., Abuaysheh, S., Green, K., Makdissi, A., Chaudhuri, A., & Dandona, P. (2016) · Clinical Endocrinology · doi:10.1111/cen.13130 · Cited by 50
“Introduction A third of men of men with type 2 diabetes have subnormal free testosterone concentrations in association with inappropriately low LH and FSH concentrations (1-4).”
BackgroundSelf-citationBiswas, M., Hampton, D., Newcombe, R. G., & Rees, D. A. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04196.x · Cited by 46
Pelusi, C., Giagulli, V. A., Baccini, M., Fanelli, F., Mezzullo, M., Fazzini, A., Bianchi, N., Carbone, M. D., De Pergola, G., Mastroroberto, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183369 · Cited by 45
Evaluation of the hypothalamic‐pituitary‐gonadal axis in eugonadal men with type 2 diabetes mellitus
Costanzo, P., Suárez, S. M., Scaglia, H. E., Zylbersztein, C., Litwak, L., & Knoblovits, P. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00163.x · Cited by 48
“However, in obesity, as well as in hyperinsulinaemia and DM2, there is also a decrease in free T (FT) and bioavailable to (BT) levels, which implies a real decline in T production (Laaksonen et al., 2003; Knoblovits et al., 2010; Dandona & Dhindsa, 2011).”
BackgroundAhangarpour, A., Oroojan, A. A., Heidari, H., Ghaedi, E., & Nooshabadi, M. R. (2014) · The World Journal of Men s Health · doi:10.5534/wjmh.2014.32.3.151 · Cited by 44
“Further, the prevalence of secondary hypogonadism in men with type-2 diabetes is at least 25%, and 4% of them have primary hypogonadism [5].”
BackgroundGregorič, N., Šikonja, J., Janež, A., & Jensterle, M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16042 · Cited by 61
Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue
Wawrzkiewicz–Jałowiecka, A., Lalik, A., & Soveral, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105226 · Cited by 52
Knapp, A., Myhill, P. C., Davis, W. A., Peters, K. E., Hillman, D., Hamilton, E. J., Lim, E. M., & Davis, T. M. E. (2014) · Clinical Endocrinology · doi:10.1111/cen.12401 · Cited by 39
De, A., Singh, M. F., Singh, V., Ram, V., & Bisht, S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.008 · Cited by 40
Ghanim, H., Dhindsa, S., Abuaysheh, S., Batra, M., Kuhadiya, N. D., Makdissi, A., Chaudhuri, A., & Dandona, P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0673 · Cited by 39
Self-citationTroncoso, M. F., Pávez, M., Wilson, C., Lagos, D., Duran, J., Ramos, S., Barrientos, G. C., Silva, P., Llanos, P., Basualto-Alarcón, C., et al. (2021) · Biological Research · doi:10.1186/s40659-021-00328-4 · Cited by 47
Independent Effects of Testosterone on Lipid Oxidation and VLDL-TG Production
Høst, C., Gormsen, L. C., Christensen, B., Jessen, N., Hougaard, D. M., Christiansen, J. S., Pedersen, S. B., Jensen, M. D., Nielsen, S., & Gravholt, C. H. (2013) · Diabetes · doi:10.2337/db12-0440 · Cited by 37
“Likewise, the effects of T therapy on glucose control (36) and risk factors such as cholesterol, C-reactive protein (37), and TG concentrations are contradictory (6–11), which calls for studies assessing direct effects of T.”
BackgroundDhindsa, S., Reddy, A., Karam, J. S., Bilkis, S., Chaurasia, A., Mehta, A., Raja, K., Batra, M., & Dandona, P. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0359 · Cited by 37
Self-citationChronic rapamycin treatment causes diabetes in male mice
Schindler, C. E., Partap, U., Patchen, B., & Swoap, S. J. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00123.2014 · Cited by 43
Report of the JDS/JCA Joint Committee on Diabetes and Cancer
Kasuga, M., Ueki, K., Tajima, N., Noda, M., Ohashi, K., Noto, H., Goto, A., Ogawa, W., Sakai, R., Tsugane, S., et al. (2013) · Diabetology International · doi:10.1007/s13340-013-0121-3 · Cited by 40
“On the other hand, it is reported that the serum testosterone concentration decreases with the onset of diabetes [36], which may account for the low incidence of prostate cancer in diabetes.”
BackgroundObesity, endocrine disruption and male infertility
Dutta, S., Biswas, A., & Sengupta, P. (2019) · Asian Pacific Journal of Reproduction · doi:10.4103/2305-0500.268133 · Cited by 47
“According to the Endocrine Society Clinical Practice Guidelines (2010), men with type 2 diabetes are subjected to be screened for low levels of testosterone[80].”
MethodStefańska, A., Ponikowska, I., Ćwiklińska-Jurkowska, M. M., & Sypniewska, G. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.49 · Cited by 39
Derkach, K. V., Bakhtyukov, A. A., Romanova, I. V., Zorina, I. I., Bayunova, L. V., Бондарева, В. М., Morina, I. Y., Roy, V. K., & Shpakov, A. O. (2020) · Andrologia · doi:10.1111/and.13816 · Cited by 37
“The data are presented as M ± SEM, n = 5 reduced blood LH levels, as well as the absence of their changes or the increased LH levels, are shown (Barrett-Connor, Khaw, & Yen, 1990; Dandona & Dhindsa, 2011).”
BackgroundStrollo, F., Strollo, G., Morè, M., Magni, P., Macchi, C., Masini, M. A., Carucci, I., Celotti, F., Ruscica, M., & Gentile, S. (2013) · The Aging Male · doi:10.3109/13685538.2013.773305 · Cited by 36
“The prevalence of this milder form of LOH is as high as 40%–60% in obese elderly men, especially those with impaired fasting glucose (IFG, fasting glucose: 101–125 mg/dL), impaired glucose tolerance (IGT, plasma glucose 4140 mg/dL 120 min after 75 g glucose ingestion), or type 2 diabetes mellitus [12].”
BackgroundThyroid Hormone and Leptin in the Testis
Ramos, C. F., & Zamoner, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00198 · Cited by 42
“OBESITY AND TESTIS The effects of obesity on testis and male reproduction have been demonstrated in recent years (90).”
BackgroundTaylor, S. R., Meadowcraft, L., & Williamson, B. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1623 · Cited by 35
“Two groups of authors proposed that obesity increases aromatase activity, and the association of obesity may contribute to androgen deficiency in men with T2DM.16,23 Aromatase, an enzyme responsible for the conversion of testosterone to estradiol, is increased in obesity due to a greater prevalence of adipocytes and c…”
BackgroundInfluentialOral glucose load and mixed meal feeding lowers testosterone levels in healthy eugonadal men
Gagliano‐Jucá, T., Li, Z., Pencina, K. M., Beleva, Y. M., Carlson, O. D., Egan, J. M., & Basaria, S. S. (2018) · Endocrine · doi:10.1007/s12020-018-1741-y · Cited by 36
Classic and Novel Sex Hormone Binding Globulin Effects on the Cardiovascular System in Men
Basualto-Alarcón, C., Llanos, P., García‐Rivas, G., Troncoso, M. F., Lagos, D., Barrientos, G. C., & Estrada, M. (2021) · International Journal of Endocrinology · doi:10.1155/2021/5527973 · Cited by 38
How much obesity and diabetes do impair male fertility?
Abbasihormozi, S., Kouhkan, A., Shahverdi, A., Parikar, A., Shirin, A., & Vesali, S. (2023) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-01034-w · Cited by 42
“Serum testosterone in obesity and diabetes is commonly associated with the development of secondary hypogonadism [10].”
BackgroundResultAndrogen-Regulated Cardiac Metabolism in Aging Men
Barrientos, G. C., Llanos, P., Basualto-Alarcón, C., & Estrada, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00316 · Cited by 36
“Additionally to testosterone reduction in elderly men, low concentrations of testosterone are also found in late-onset hypogonadism, reduction of testicular volume and malfunction of the androgen production machinery, systemic accelerated testosterone metabolism and expression of defective androgen receptors (24, 25,…”
BackgroundStefańska, A., Sypniewska, G., Ponikowska, I., & Ćwiklińska-Jurkowska, M. M. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.03.011 · Cited by 35
“The association of follicle-stimulating hormone (FSH) concentration with type 2 diabetes andMetS iswell documented inmenand is controversial in premenopausalwomenwith polycystic ovary syndrome (PCOS) [4,5].”
BackgroundInfluentialNesfatin-1 ameliorates type-2 diabetes-associated reproductive dysfunction in male mice
Ranjan, A. K., Choubey, M., Yada, T., & Krishna, A. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01136-0 · Cited by 31
Adiponectin Receptors in Energy Homeostasis and Obesity Pathogenesis
Akingbemi, B. T. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386933-3.00009-1 · Cited by 33
Matsui, H., & Asami, T. (2014) · Neuroendocrinology · doi:10.1159/000357809 · Cited by 40
Hypothalamic reproductive neurons communicate through signal transduction to control reproduction
McIlwraith, E. K., & Belsham, D. D. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110971 · Cited by 39
Osmancevic, A., Daka, B., Michos, E. D., Trimpou, P., & Allison, M. (2023) · Clinical Endocrinology · doi:10.1111/cen.14930 · Cited by 34
“Previous studies have shown that diabetes mellitus negatively influences levels of testosterone.36 Certain ethnicities/ races have been presented to be more prone to develop T2DM.37 Further studies are required to confirm this relationship.”
BackgroundInfluentialDeshpande, S., Nemani, H., Pothani, S., Khambata, K., Kumar, A. V., Kallamadi, P. R., & Balasinor, N. (2018) · Endocrinology · doi:10.1210/en.2018-00569 · Cited by 33
Glucagon-like peptide-1 receptor expression and its functions are regulated by androgen
Zhu, L., Zhou, J., Pan, Y., Lv, J., Liu, Y., Yu, S., & Zhang, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109555 · Cited by 27
Vitamin D Deficiency in Type 2 Diabetic Patients with Hypogonadism
Bellastella, G., Maiorino, M. I., Olita, L., Capuano, A., Rafaniello, C., Giugliano, D., & Esposito, K. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12384 · Cited by 30
Negative Effects of High Glucose Exposure in Human Gonadotropin-Releasing Hormone Neurons
Morelli, A., Comeglio, P., Sarchielli, E., Cellai, I., Vignozzi, L., Vannelli, G. B., & Maggi, M. (2013) · International Journal of Endocrinology · doi:10.1155/2013/684659 · Cited by 33
“Several studies have documented that insulin resistance is the most important factor responsible for the association between low testosterone and T2DM ([15], for review), although conflicting results exist about the level—central and/or peripheral—at which the underlying pathogenic mechanisms may interfere with the HP…”
BackgroundInfluentialAndrogen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes
Saghier, E. O. A. E., Shebl, S. E., Fawzy, O., Eltayeb, L. M., Bekhet, L. M. A., & Gharib, A. (2015) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s27700 · Cited by 31
Mohammed, M., Al‐Habori, M., Abdullateef, A. A., & Saif-Ali, R. (2018) · Journal of Diabetes Research · doi:10.1155/2018/4926789 · Cited by 34
“in free testosterone to levels, which implies a real decline in testosterone production [9, 40, 41] in which Leydig cell steroidogenesis is impaired because of target organ resistance to insulin action and/or production of cytokines/hormones by the adipose tissue [35, 42].”
BackgroundType 2 diabetes mellitus and the risk of male infertility: a Mendelian randomization study
Zhu, X.-B., Niu, Z.-H., Fan, W.-M., Sheng, C.-S., & Chen, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1279058 · Cited by 28
Effects of Bariatric Surgery in Male Obesity-Associated Hypogonadism
Rigon, F. A., Ronsoni, M. F., Hohl, A., & van de Sande-Lee, S. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03829-0 · Cited by 27
Fu, H., Bai, X., Le, L., Tian, D., Gao, H., Qi, L., & Hu, K. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/1782953 · Cited by 33
Chi, Y., Jian, Z., Gao, X., Jin, X., Wang, M., Xiang, L., Li, H., & Wang, K. (2021) · Andrology · doi:10.1111/andr.13132 · Cited by 34
Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men
Bendre, S. V., Murray, P. J., & Basaria, S. S. (2015) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.1000155 · Cited by 26
Vagal pathways for systemic regulation of glucose metabolism
Borgmann, D., & Fenselau, H. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.07.010 · Cited by 30
The relation between obesity, kisspeptin, leptin, and male fertility
Ghaderpour, S., Ghiasi, R., Heydari, H., & Keyhanmanesh, . (2021) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2021-0058 · Cited by 31
Stefańska, A., Cembrowska, P., Kubacka, J., Kuligowska-Prusińska, M., & Sypniewska, G. (2019) · Disease Markers · doi:10.1155/2019/2384069 · Cited by 33
“So far, two cross-sectional studies have evaluated the association between LH/FSH ratio and metabolic disturbances in postmenopausal women, outside the context of the PCOS diagnosis.”
BackgroundInfluential
Metadata
- Authors
- Dandona, P., & Dhindsa, S.
- Affiliations
- Kaleida Health (US)
- Corresponding author
- Dandona, Paresh
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-09-01
- Volume
- 96
- Issue
- 9
- Pages
- 2643-2651
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3167667
- OpenAlex
- W2111728603
- Semantic Scholar
- fecffda5a7c16c9bb49b9b21398e4d0afefbc568
- Cited by
- 313
- References
- 75
- Citations by year
- 2026: 15 · 2025: 15 · 2024: 16 · 2023: 22 · 2022: 18 · 2021: 24 · 2020: 14 · 2019: 19 · 2018: 29 · 2017: 19 · 2016: 16 · 2015: 27 · 2014: 24 · 2013: 36 · 2012: 17
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk069805-04)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK069805, R01DK075877)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hypogonadotropic hypogonadism, type 2 diabetes, obesity, androgen deficiency, free testosterone, luteinizing hormone, follicle-stimulating hormone, testosterone replacement therapy, insulin sensitivity, cardiovascular risk, C-reactive protein, anemia, sexual function, erectile dysfunction, phosphodiesterase inhibitors, waist circumference
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypogonadism, Male, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.